Sort
15,842 grants matching “pancreatic cancer”
University of Minnesota Clinical Center for the Study of Pancreatic Disease
$80,001Melena D. Bellin · University Of Minnesota · U01 · FY2024 · DK
Role of CRABP-II in pancreatic cancer metastasis
$80,000Shuiliang Yu · Case Western Reserve University · R03 · FY2018 · CA
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level
$80,000Agne Petrosiute · Case Western Reserve University · R03 · FY2018 · CA
Role of CRABP-II in pancreatic cancer metastasis
$80,000Shuiliang Yu · Case Western Reserve University · R03 · FY2017 · CA
IRF2BP2 modification by Cdk5 modulates interferon-gamma response tumor PD-L1 level
$80,000Agne Petrosiute · Case Western Reserve University · R03 · FY2017 · CA
The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center
$80,000Philip A. Hart · Ohio State University · U01 · FY2024 · DK
Career Enhancement Program
$79,999William E Gillanders · Washington University · P50 · FY2017 · CA
Racial contributions of microenvironment remolding during pancreatic metaplasia
$79,951Jamel Ali · Florida Agricultural And Mechanical Univ · U54 · FY2023 · CA
Epigenetic regulation of metabolic rerpogramming in pancreatic cancer
$79,750Alexandros Tzatsos · George Washington University · R03 · FY2017 · CA
Epigenetic regulation of metabolic rerpogramming in pancreatic cancer
$79,750Alexandros Tzatsos · George Washington University · R03 · FY2018 · CA
Predicted lean body mass, fat mass, and risk of lung, pancreatic, colorectal, breast, and prostate cancers
$79,750Edward Giovannucci · Harvard School Of Public Health · R03 · FY2019 · CA
Predicted lean body mass, fat mass, and risk of lung, pancreatic, colorectal, breast, and prostate cancers
$79,750Edward Giovannucci · Harvard School Of Public Health · R03 · FY2018 · CA
Histone methyltransferase EZH2 in liver pathophysiology and carcinogenesis
$79,750Hong Lu · Upstate Medical University · R03 · FY2012 · CA
Histone methyltransferase EZH2 in liver pathophysiology and carcinogenesis
$79,750Hong Lu · Upstate Medical University · R03 · FY2011 · CA
Predicting Response of Pancreatic Tumors to Therapy
$79,686Elizabeth Repasky · Roswell Park Cancer Institute Corp · R03 · FY2007 · CA
BRCA1 and Familial Pancreatic Cancer
$79,622Alison P Klein · Johns Hopkins University · R03 · FY2007 · CA
Fluorophore-Conjugated Antibodies for Imaging and Resection of GI Tumors
$79,602Michael Bouvet · University Of California, San Diego · R01 · FY2015 · CA
LCM & 2D PAGE in Early Detection of Pancreatic Cancer
$79,350Sulma Ibrahim Mohammed · Purdue University · R03 · FY2006 · CA
RNases for understanding the origin of new gene function
$79,268Jianzhi Zhang · University Of Michigan At Ann Arbor · R01 · FY2008 · GM
BK Channel Inhibition by Nobiletin
$79,250Frank T Horrigan · Baylor College Of Medicine · R03 · FY2017 · NS
Allogeneic antibody therapy for malignant mesothelioma
$79,250Bryan Michael Burt · Baylor College Of Medicine · R03 · FY2016 · CA
BK Channel Inhibition by Nobiletin
$79,250Frank T Horrigan · Baylor College Of Medicine · R03 · FY2018 · NS
Cloning of Zebrafish exocrine pancreas mutant
$79,250University Of Pennsylvania · R03 · FY2005 · DK
Allogeneic antibody therapy for malignant mesothelioma
$79,250Bryan Michael Burt · Baylor College Of Medicine · R03 · FY2017 · CA
Pancreatic cystic lesions: descriptive epidemiology and natural history
$79,188Paige M. Bracci · University Of California, San Francisco · R03 · FY2015 · CA